Human FXII,
FXIIa, PK,
α-kallikrein and
plasmin were from Enzyme Research Laboratory (South Bend, IN). Human factor XIa was from Haematologic Technologies (Burlington, VT).
Type I fibrillar collagen was from Chrono-Log (Havertown, PA). Anhydrous iron (III) chloride (FeCl
3, molecular mass 160.20 Daltons) and delipidated bovine serum albumin (BSA) was from Sigma-Aldrich.
Phosphatidylcholine:phosphatidylserine (PC/PS) vesicles were form Avanti Polar Lipids (Alabaster, Alabama). S-2366 (L-pyro-Glu-L-Pro-L-Arg-
p-nitroanilide) and S2302 (H-D-prolyl-L-phenylalanyl-L-arginine-p-nitroaniline dihydrochloride.) were from DiaPharma (West Chester, OH).
Z-Gly-Gly-Arg-AMC was from Bachem (Torrance, CA). PTT A silica-based activated partial thromboplastin time (aPTT) reagent was from Diagnostic Stago (Parsippany, NJ). Human genomic DNA was isolated from blood leukocytes by conventional phenol:chloroform extraction.
Kokoye Y., Ivanov I., Cheng Q., Matafonov A., Dickeson S.K., Mason S., Sexton D.J., Renné T., McCrae K., Feener E.P, & Gailani D. (2016). A Comparison of the Effects of Factor XII Deficiency and Prekallikrein Deficiency on Thrombus Formation. Thrombosis research, 140, 118-124.